Paul Hartmann AG (FRA:PHH2) ROCE % : 7.98% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Paul Hartmann AG's annualized ROCE % for the quarter that ended in Dec. 2023 was 7.98%.

Paul Hartmann AG ROCE % Historical Data

The historical data trend for Paul Hartmann AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paul Hartmann AG ROCE % Chart

Paul Hartmann AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

9.05

13.22

10.51

4.57

4.32

Paul Hartmann AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															10.14	1.18	7.99	0.65	7.98

Paul Hartmann AG ROCE % Calculation

Paul Hartmann AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	64.808	/	( ( (2006.477 - 502.52)	+	(1986.787 - 489.722) )	/ 2 )
	=	64.808	/	( (1503.957	+	1497.065)	/ 2 )
	=	64.808	/	1500.511
	=	4.32 %

Paul Hartmann AG's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	119.898	/	( ( (1994.684 - 487.614)	+	(1986.787 - 489.722) )	/ 2 )
	=	119.898	/	( ( 1507.07	+	1497.065 )	/ 2 )
	=	119.898	/	1502.0675
	=	7.98 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Paul Hartmann AG (FRA:PHH2) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Paul Hartmann AG ROCE % Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Paul Hartmann AG (FRA:PHH2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

PHH2:Germany

Address

Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522

Website

http://www.hartmann.info

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.

Executives

Eduard Schleicher	Supervisory Board
Britta Fünfstück	Board of Directors

Paul Hartmann AG (FRA:PHH2) Headlines

No Headlines